期刊文献+

HLA-DRB1基因多态性与慢性髓性白血病的相关性研究 被引量:4

Association between HLA-DRB1 allele polymorphism and susceptibility to chronic myelogenous leukemia in Chinese Han
下载PDF
导出
摘要 目的:探讨HLA-DRB1等位基因多态性与慢性髓性白血病(CML)关联性。方法:采用序列特异性引物聚合酶链反应(PCR-SSP)DNA分型技术对762例慢性髓性白血病患者(男性492例,女性270例)及2 264例正常对照进行了HLA-DRB1基因分型。结果:正常人群的HLA-DRB1*15等位基因频率最高(17.25%),其次为DRB1*09(14.05%)、DRB1*12(11.73%)和DRB1*04(10.98%),DRB1*10等位基因频率最低(1.39%)。CML患者HLA-DRB1*08等位基因频率显著高于正常对照组(7.48%vs 5.39%,χ2=8.963,OR=1.023,P=0.004),男性患者的DRB1*08基因频率也明显高于正常对照(7.72%vs 5.39%,χ2=8.059,OR=1.025,P=0.007)。女性患者的DRB1*08基因频率也高于正常对照(7.04%vs 5.39%,χ2=0.115,OR=0.995,P=0.774),但没有统计学差异。结论:CML男性患者HLA-DRB1*08的表达明显高于正常人群,提示DRB1*08可能是男性CML患者的易感基因。 Objective:The aim was to explore the association between the HLA-DRB1 allele polymorphism and susceptibility to chronic myelogenous leukemia(CML) in Chinese Han population.Methods:The polymorphism of HLA-DRB1 alleles in 762 CML patients and 2 264 normal umbilical cord blood samples were tested by polymerase chain reaction with sequence specific primer(PCR-SSP).Results:The most common allele in DRB1 locus in normal population was DRB1*15(17.25%),whereas DRB1*10 was the least frequent allele(1.39%).Compared with normal controls,the frequency of HLA-DRB1*08 was significantly increased in all CML groups(7.48% vs 5.39%,χ2=8.963,OR=1.023,P=0.004) and CML male groups(7.72% vs 5.39%,χ2=8.059,OR=1.025,P=0.007).But there was no significant difference between the normal controls and CML female patients.Conclusion:It should be concluded that DRB1*08 could be considered a susceptible allele for CML male patients.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第4期309-311,共3页 Chinese Journal of Immunology
基金 教育部创新团队发展计划基金(No.IRT0702) 国家高科技研究发展项目(863计划)(No.2006AA02A405)
关键词 HLA-DRB1 慢性髓性白血病 基因多态性 基因频率 HLA-DRB1 gene Chronic myelogenous leukemia Genetic polymorphism Gene frequency
  • 相关文献

参考文献16

  • 1Posthuma E F, Falkenburg J H, Apperlry J F et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia[J]. Blood, 1999; 93:3863-3865. 被引量:1
  • 2Mundhada S, Luthra R, Cano P. Association of HLA class Ⅰ and class Ⅱ genes with bcr-abl transcripts in leukemia patients with t (9; 22)(q34; q11)[J] .BMC Cancer,2004;4:25. 被引量:1
  • 3Yasukawa M, Ohminami H, Kojima K et al. Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogenous leukemia[J]. Am J Hematol,2000;63:99-101. 被引量:1
  • 4Posthuma E F M, Falkenburg J H F, Apperley J F et al. HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia ( CML ) [ J ]. Leukemia, 2000; 14: 859-862. 被引量:1
  • 5魏丽,肖露露,吴祥元,林曲,董敏,温景芸,马小琨,仲飞.广东地区CML患者中HLA-A,B,DRB1的表达与分析[J].中国实验血液学杂志,2008,16(4):915-918. 被引量:5
  • 6李丹,郗斌,于燕,刘海燕.HLA与慢性粒细胞白血病相关性调查[J].中国输血杂志,2001,14(4):243-244. 被引量:11
  • 7Mannering S I, McKenzie J L, Fearnley D B et al. HLA-DR1- restricted bcr-abl (b3a2)-specific CD4^+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates [ J ]. Blood, 1997; 90: 290-297. 被引量:1
  • 8ten Bosch G J A, Toomvliet A C, Friede T et al. Recognition of peptides corresponding to the joining region of p210 bcr-abl protein by human T ceils[ J ]. Leukemia, 1995 ; 9 : 1344-1348. 被引量:1
  • 9ten Bosch G J A, Joosten A M, Kessler J H et al. Recognition of BCR-ABL positive leukemic blasts by human CD4^+ T cells elicited by primary in vit-ro immunization with a BCR-ABL breakpoint peptide[J]. Blood, 1996;88: 3522-3527. 被引量:1
  • 10Pawelec G, Max H, Halder T et al. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors[J]. Blood, 1996;88:211-218. 被引量:1

二级参考文献17

  • 1[1]Bortin MM,Amaro J,Bach FH,et al.HLA associations with leukemia.Blood, 1987,70:227 被引量:1
  • 2[2]Revesz T,Benczur M,Gyodi E,et al.The association of HLA-DR5 antigen with longer survival in childhood leukemia.Br J Heamatol, 1981,48:508 被引量:1
  • 3[3]Linet MS,Bias WB,Dorgan JF,et al.HLA antigens in chronic lymphocytic leukemia.Tissue Antigens,1988,31:71 被引量:1
  • 4[4]Hester JP,Rossen R,Trwillo J,et al.Frequency of HLA antigens in chronic myelocytic leukemia.South Med J,1977,70:691 被引量:1
  • 5[5]Ruuska P,Silvennoinen-Kassinen S,Timonen T,et al.Chronic myelocytic leukemia:HLA association and decreased erythrocyte C3b receptor expression.Clin Exp Immunol,1985,59:300 被引量:1
  • 6[6]Olerup O,Zetterquist H.HLA-DR typing by PCR amplification with sequence-specific primers(PCR-SSP) in 2 hours:an alternative to serological DR typing in clinical practice including donor- recipient matching in cadaveric transplantation.Tissue Antigens, 1992,39:225 被引量:1
  • 7[7]John Lee.The HLA system-a new approach.New York.Springer,1990,141~178 被引量:1
  • 8Posthuma EF, Falkenburg JH, Apperlry JF, et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. Blood, 1999; 93 : 3863 - 3865 被引量:1
  • 9Mundhada S, Luthra R, Carlo P. Association of HLA Class Ⅰ and Class Ⅱ genes with bcr-abl transcripts in leukemia patients with t(9; 22) (q34;q11). BMC Cancer,2004;4:25 被引量:1
  • 10Yasukawa M, Ohminami H, Kojima K, et al. Analysis of HLADRB1 alleles in Japanese patients with chronic myelogenous leukemia. Am J Hematol, 2000;63:99 - 101 被引量:1

共引文献14

同被引文献39

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部